金活医药集团2025年中期报告

(於開曼群島註冊成立的有限公司)股份代號: 01110 2025中 期 報 告 0102040543555657585960 Ocorian Trust (Cayman) LimitedWindward 3, Regatta Office ParkPO Box 1350Grand Cayman KY1-1108Cayman Islands 198A8-9 8086613 1617 Ocorian Trust (Cayman) LimitedWindward 3, Regatta Office ParkPO Box 1350Grand Cayman KY1-1108Cayman Islands 1513 779 9028B1-29 01110 359-36112 www.kingworld.com.cn (1)(2)(3)100% 15%20% 266.225.3% 443.2% 21.510.6% 1.5315.4% 12%18%KOL 13 1) 20411.5%(B2C)(B2B)182,677151,58920,41410,6551910% 191400 2) 448 臺359.6 22820 3) 臺CCTV-8臺 臺臺•60OTC臺 4 1.0 CarmexINNOPHARM臺1 1 INNOPHARM臺臺77760461703臺50200臺3091%臺29%臺 CarmexCosplay1825臺145##Cosplay#12+182533%24% 2 INNOPHARM臺 臺 + 3 ASAM50PrecisionBiotics(Novonesis)26 臺臺HKTVMALL臺INNOPHARMINNOPHARM臺 INNOPHARMFACEBOOKWINNYWINCYSIRONLINE30+ 4 (GMP) 5 6S118.44.0% SW3200 Basic2kg91CMEF 1 CMEF臺 2 3 1 • 臺25 OTC 臺臺72 2 臺 300831424113 AI 2.0臺AIAIAIAI 1. 臺75913726136361 2. 703,457,6001,397,600192,060,00051 680,000 3 • •• •• •• 3.8 1. 404,850,000526,088,000121,238,00023.0% 2. 302,807,000388,828,00086,021,00022.1%26.1%25.2% 3. 7,877,0004,222,0003,655,00086.6%(7) 4. 43,592,00048,565,0004,973,00010.2% 5. 55,020,00042,708,00012,312,00028.8% 6. 15,958,00057,929,00041,971,00072.5%35,217,000 7. 8,085,0009,316,0001,231,00013.2% 8. 13,874,00055,466,00041,592,00075.0% 9. 2,438,0009,846,0007,408,00075.2%16.4%17.8%(9) 10. 11,436,00045,620,00034,184,00074.9% 11. 5,412,00030,716,000 12. 3.3%7.0% 230,541,000235,299,000 13. 4,758,0005,884,0007,516,0002,191,000935,00059 14. 413,754,000387,616,000 26.2%21.6%100% 111,600,00092,681,000207,610,000107,000,00094,257,00015,526,000 1,955,00054,919,000 15. 15% 16. 17. 660,5365.3%245,4585.0%21,8405.4% 217,8762.9%137.2%979.50.23%545.393.80% 1,3143.4%9.2%0.3%30.1%OTC 2217830077%80% 2695641744559820700 14 148518 3,400臺++ 2,000OTC4127.67%2,9612.2% OTC+ 7591372613636161,110,00066,559,000 (a) XV(i)XV78(ii)352(iii) 1.24,720,000388,260,250 (a)297,812,250297,812,250(b)448,00090,000,000448,00090,000,000 2.412,980,250 (a)448,00090,000,00090,000,000(b)24,720,000297,812,25024,720,000297,812,250 3.296,0002,380,000 XV(i)XV78(ii)352(iii) XV23 (b) XV23336 1.24,720,000388,260,250 (a)297,812,250297,812,250 (b)448,00090,000,000448,00090,000,000 2.412,980,250 (a)448,00090,000,00090,000,000(b)24,720,000297,812,25024,720,000297,812,250 3.Sinopharm Capital LimitedSinopharm Healthcare Fund L.P. 1.79% XV23336 (a)10%622,500,00030%(b)1%(c)(i)(ii)(iii)(d)10(e)(f) (i)(ii)(iii) 0.1% 16,000,000 46,000,0007.39% (I)(A)(B) (II) 1010 (A)(B) (III) (IV) (i)(ii)(iii) (V) (i)(ii)10%0.5% 17.03(13) (VI) (A)120.1% (B)120.1%13.4013.4113.42 12(i)1%(ii) (VII) (i)(ii) 1212 (A)(B)(C)(D)(E)12(F)12 1,868,00012,553,000 25% 3.1719,733,00018,026,000 C1 C.2.1 C.2.1 C3 703,457,6001,397,600192,060,00051 622,500,0000.55%0.550.558 (http://www.hkexnews.hk)http://www.kingworld.com.cn 1. 22(i)(ii) 2. 3434 34 3. 21 4. 5. – – 5. (a) EBITDA為為EBITDA 6. 7. 8. 9. 9. (i)(ii)16.5%16.5%28.25%16.5%(iii25%25%15%15%(iv)10%25%5%[2008]15% 10. 11. (a) (b) 12. 10,489,000240,000 1,955,00054,919,000 207,610,00015,526,00092,681,00094,257,00017 13. (a)(i)(ii) (b) (c)111,600,000107,000,00017 14. 30120 15. 4590 16. 0.1 17. 90% 18. 13 18. 19.